Abstract
HER-conjugated hollow nanoparticles (HER-HNP, ca. 50 nm in diameter) are fabricated using a dissolution and re-deposition method and used to encapsulate camptothecin (CPT). The HER-HNP-CPT is used as an anti-cancer agent for human breast cancer SK-BR-3. It has excellent mono-dispersity and a high loading efficiency for CPT. Two kind of cell lines are used in this study; SK-BR-3 and RAW 264.7. SK-BR-3 and RAW 264.7 are used as targeting and controlling cell line, respectively. When SK-BR-3 cells are treated with HER-HNP-CPT, the viability decreased to 55%, which is ca. 1.5 times higher anti-cancer efficiency in comparison to RAW 264.7. The HER-HNP-CPT system offers a new opportunity to facilitate implementation of a hydrophobic drug for effective anti-cancer treatment of SK-BR-3 cells.
Similar content being viewed by others
References
K. Cheng, N. J. Rahier, B. M. Eisenhauer, R. Gao, S. J. Thomas, S. M. Hecht, J. Am. Chem. Soc. 127, 838 (2005)
D. Sriram, P. Yogeeswari, R. Thirumurugan, T. R. Bal, Nat. Prod. Res. 19, 393 (2005)
N. Zhao, J. You, Z. Zeng, C. Li, Y. Zu, Small 9, 3477 (2013)
W. K. Oh, S. Kim, M. Choi, C. Kim, Y. S. Jeong, B. R. Cho, J. S. Hahn and J. Jang, ACS nano 4, 5301 (2010)
Z. H. Chen, C. Kim, X.-B. Zeng, S. H. Hwang, J. Jang, G. Ungar, Langmuir 28, 15350 (2012)
W. Stçber, A. Fink, E. Bohn, J. Colloid Interface Sci. 26, 62 (1968)
G. Bogush, M. Tracy and C. Zukoski, J. Non-Cryst. Solids 104, 95 (1988)
J. Lu, M. Liong, J. I. Zink, F. Tamanoi, Small 3, 1341 (2007)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jang, Y., Jang, J. CPT Encapsulated Silica-titania Hollow Nanoparticle Targeting SK-BR-3 Cells for efficient Anticancer treatment. MRS Online Proceedings Library 1725, 35–40 (2014). https://doi.org/10.1557/opl.2015.166
Published:
Issue Date:
DOI: https://doi.org/10.1557/opl.2015.166